San Diego-centered Viking Therapeutics marked by itself as a serious competitor within the weight loss drug market in February following revealing promising knowledge from the mid-stage demo of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when specified for a weekly injection and in March the compan… Read More